Weekly Dose of Top 5 Healthcare Stories You Might’ve Missed
From our partner site, Healthcare Dive, we wanted to share the top…
Pfizer and Hospira: It’s Not About Generics
Did somebody say generic? Did somebody say generic?Leading newspapers, including the Wall…
Pfizer Joins Microbiome Movement with Second Genome
First published on MedCityNews.com. Scientific understanding of the microbiome – the ecosystem of…
Pfizer to Expand Clinical Trial Data Access, Takes Step Toward Transparency
Pfizer Inc. Pfizer Inc. updated its clinical trial data access policy yesterday, and will…
Sorry Lipitor, You’re No Match for Generics
Pfizer received a flurry of attention toward the end of November as…
Pfizer Has a New Sales Strategy–Will Be Selling Lipitor at Generic Prices When Patent Runs Out
Well this stands to certainly keep more patients taking “name” brand Lipitor…
Lipitor: How Pfizer Hopes to Slow the Decline
By all rights, Pfizer’s Lipitor revenues should drop like a stone once…
A High Price for Rare Cancer Drugs
Pfizer last week won Food and Drug Administration “accelerated approval” for Xalkori…
Smart Money on Pfizer?
Seeking Alpha highlights what leading hedge funds are doing with Pfizer. Some…
Another Reason Health Costs Are So High
Pfizer Inc. wants to introduce a version of its popular cholesterol pill Lipitor…
